How many drugs treat Hypomagnesemia?

Drug Landscape tracks 3 marketed treatments for Hypomagnesemia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hypomagnesemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hypomagnesemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypomagnesemia (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hypomagnesemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	First approval
Renacidin	MAGNESIUM CARBONATE	United Guardian	Vitamin C [EPC]	1990-01-01
Prepopik	MAGNESIUM OXIDE	Baxter	magnesium oxide	1982-01-01
Plegisol In Plastic Container	MAGNESIUM CHLORIDE	Pfizer	magnesium chloride	1975-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 2 drugs in Hypomagnesemia
Baxter · 1 drug in Hypomagnesemia
Pfizer · 1 drug in Hypomagnesemia
United Guardian · 1 drug in Hypomagnesemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hypomagnesemia:

Cite this brief

Drug Landscape (2026). Hypomagnesemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hypomagnesemia. Accessed 2026-06-10.

Hypomagnesemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing